A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Skin Quality Deficit
Interventions
DEVICE

JUVÉDERM® VOLITE™

Injection, intradermal

OTHER

Control

No-treatment control

Trial Locations (6)

100029

China-Japan Friendship Hospital /ID# 260959, Beijing

100034

Peking University First Hospital /ID# 260957, Xicheng District

200040

Huashan Hospital, Fudan University /ID# 261582, Shanghai

210008

Nanjing Drum Tower Hospital /ID# 260950, Nanjing

210009

Zhongda Hospital Southeast University /ID# 260951, Nanjing

310003

Hangzhou First People's Hospital /ID# 260952, Hangzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY